Defining factors that can predict neoadjuvant chemotherapy response in breast cancer - European Medical Journal

Defining factors that can predict neoadjuvant chemotherapy response in breast cancer

Oncology

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the University of Dundee, Dundee, United Kingdom, discusses tumour parameters, including the size of peritumoural stiffness on 2D shear wave elastography (SWE), for predicting the response of a patient with breast cancer to neoadjuvant chemotherapy.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now